drugset

drugset / Trial / NCT06493461

A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults

NCT06493461 ↗

Phase 1 Terminated 5 enrolled 35Pharma Inc

NaSequentialOpen-labelTreatment

Summary

A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults

Timeline

Start: 2024-10-23
Primary completion: 2025-03-31
Completion: 2025-03-31

Outcome

Outcome not reported

Stopped: “Sponsor's Decision”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HS135	Unknown	—	Subcutaneous

Indications